RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell combo shows promise in tough head and neck cancers
Disease control CompletedThis early-phase study tested a new treatment combining immune-boosting drugs with specially trained natural killer (NK) cells in 11 people with advanced head and neck cancer that had returned or spread. The goal was to see if the combination was safe and could shrink tumors. Whi…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
New combo therapy shows promise for tough head and neck cancers
Disease control CompletedThis study tested a treatment that combines a short, intense type of radiation (quad-shot) with immunotherapy drugs for people with advanced or recurrent head and neck cancer that cannot be cured. The goal was to see if this combination could shrink tumors and be tolerable. The s…
Matched conditions: RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 22, 2026 13:50 UTC